Thursday, 30 September 2021 | 15:00-16:30 | Room 1
Substantial progress has been made in cancer care in the past decade. However, the increasing burden of cancer due to demographic change will increase the global burden of cancer despite advances in cancer care, a trend to be exacerbated by the COVID-19 pandemic.
As the hallmark annual event for the MSD Oncology Policy Grant Program, this session will discuss affordable access to cancer care from the global to the local level. Facilitated by Panos Kanavos of the London School of Economics and Political Science, this session will examine research and recommendations on topics including: the impact of the Innovation Fund on access to innovative cancer medicines in Italy, the value assessment of expanded indication drugs in South Korea, data-driven cancer policy in Poland and the socioeconomic impact of cancer and innovative reimbursement tools in Spain.
Join us to discuss the future of cancer care research, funding, and policy across Europe and the world, together with experts from science and academia, the public and private sectors, and civil society.